DLHAX
Price
$26.89
Change
+$0.10 (+0.37%)
Updated
Oct 8 closing price
Net Assets
681.9M
JNGLX
Price
$74.56
Change
+$0.48 (+0.65%)
Updated
Oct 8 closing price
Net Assets
4.49B
Interact to see
Advertisement

DLHAX vs JNGLX

Header iconDLHAX vs JNGLX Comparison
Open Charts DLHAX vs JNGLXBanner chart's image
Macquarie Healthcare A
Price$26.89
Change+$0.10 (+0.37%)
VolumeN/A
Net Assets681.9M
Janus Henderson Global Life Sciences D
Price$74.56
Change+$0.48 (+0.65%)
VolumeN/A
Net Assets4.49B
DLHAX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
DLHAX vs. JNGLX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHAX is a StrongBuy and JNGLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.49B vs. DLHAX (682M). JNGLX pays higher dividends than DLHAX: JNGLX (0.33) vs DLHAX (0.09). DLHAX was incepted earlier than JNGLX: DLHAX (18 years) vs JNGLX (27 years). DLHAX (1.25) is less costly to investors than JNGLX (0.80). JNGLX is a more actively managed with annual turnover of: 35.00 vs. DLHAX (5.00). DLHAX has a lower initial minimum investment than JNGLX: DLHAX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -6.32 vs. DLHAX (-7.63). JNGLX return over 5 years is better than : 7.83 vs. DLHAX (-4.26).
DLHAXJNGLXDLHAX / JNGLX
Total Expense Ratio1.210.80151%
Annual Report Gross Expense Ratio1.250.80156%
Fund Existence18 years27 years-
Gain YTD12.8009.118140%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets682M4.49B15%
Annual Yield % from dividends0.090.3328%
Returns for 1 year-7.63-6.32121%
Returns for 3 years9.0824.1838%
Returns for 5 years-4.267.83-54%
Returns for 10 years38.1240.2495%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGLEX20.380.07
+0.34%
Putnam Focused International Equity R6
ACAAX44.39N/A
N/A
Alger Capital Appreciation A
ACIHX70.41N/A
N/A
American Century Growth G
DHAMX16.90N/A
N/A
Centre American Select Equity Advisor
AHSZX20.91N/A
N/A
Alger Health Sciences Z